Pharmaceutical Executive announces winners of 2024 Pharmaceutical Executive APEX Awards
| OSTGX Fund | USD 18.92 0.03 0.16% |
Slightly above 54% of Osterweis Emerging's investor base is interested to short. The analysis of overall sentiment of trading Osterweis Emerging Opportunity mutual fund suggests that many investors are impartial at this time. Osterweis Emerging's investing sentiment can be driven by a variety of factors including economic data, Osterweis Emerging's earnings reports, geopolitical events, and overall market trends.
Osterweis |
CRANBURY, N.J., Nov. 27, 2024 -- Its an appointment with excellence The Pharmaceutical Executive APEX Awards, the only advertising awards program judged exclusively by doctors, nurses and other health care heroes, proudly announced winners of its 2024 competition. This year, 30 industry leaders and globally recognized creative agencies participated, sharing campaigns that upraised therapies, treatment options, institutions and other breakthroughs to advance human health. Wer
Read at finance.yahoo.com
 |
Osterweis Emerging Fundamental Analysis
We analyze Osterweis Emerging's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Osterweis Emerging using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Osterweis Emerging based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Osterweis Emerging is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Osterweis Emerging Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Osterweis Emerging mutual fund to make a market-neutral strategy. Peer analysis of Osterweis Emerging could also be used in its relative valuation, which is a method of valuing Osterweis Emerging by comparing valuation metrics with similar companies.
Peers
Osterweis Emerging Related Equities
| BCGDX | Blue Current | 0.62 | ||||
| RGPAX | Rbc Global | 0.61 | ||||
| CNGLX | Commonwealth Global | 0.32 | ||||
| MGKAX | Morgan Stanley | 0.29 | ||||
| WRLDX | Scharf Global | 0.24 | ||||
| MFIRX | Ms Global | 0.19 | ||||
| APDPX | Artisan Global | 0.29 |
Other Information on Investing in Osterweis Mutual Fund
Osterweis Emerging financial ratios help investors to determine whether Osterweis Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Osterweis with respect to the benefits of owning Osterweis Emerging security.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |